HealthifyMe: Building an AI-Assisted Nutrition and Fitness Platform
Industry & Competitive Context
HealthifyMe was founded in 2012 by Tushar Vashisht, Sachin Shenoy and Mathew Cherian and offers nutrition and calorie tracking alongside fitness coaching. Its commercial model is freemium. The CEO told reporters in 2018 that the company began monetising through nutritionist and trainer subscriptions about two years earlier, and concluded that much of that work could be done by AI. By 2019 plans ranged up to ₹1,500 with human coaching, down to a ₹299 plan powered entirely by its AI assistant.
Demand conditions shifted sharply during the pandemic. Filings with the Registrar of Companies show the Indian entity’s revenue rose from ₹86.05 crore in FY21 to ₹185.25 crore in FY22. The competitive set is broad. An IMARC market report on India’s fitness-app sector profiles Cult.fit, HealthifyMe, FITPASS, MyFitnessPal, Google (Fitbit), Samsung and Strava, among others. The category spans workout apps, wearables, gym-linked platforms and nutrition trackers, so HealthifyMe competes across several adjacent segments rather than one clean market.
The category’s frontier has moved toward clinical territory. In December 2025 Reuters reported that Healthify had launched a patient-support programme with Novo Nordisk’s Indian unit, and that the CEO described its GLP-1 weight-management programme as its fastest-growing. By 2026 the US opportunity was framed as insurance-covered metabolic care, including GLP-1 care.
Brand Situation Prior to the AI Repositioning
By 2017 HealthifyMe’s proposition was already hybrid. Coverage of the October 2017 launch described the app as combining technology with real human services. Its binding constraint was coach capacity. The CEO said one nutritionist could initially handle 40 customers, and that optimisation and technology integration had raised that to 100.
The company also held two proprietary assets. The first was data: 150 million tracked meals and 10 million coach–client message exchanges. The second was an internal AI layer. Jarvis, which the company said was built about three years before the 2017 launch, helps coaches work more efficiently by learning from their client interactions. Ria was presented as the next evolution of Jarvis, developed under the codename “Project Amadeus.”
Capital followed. HealthifyMe raised $12 million in February 2018 to deepen its AI capabilities. It raised a $75 million Series C in July 2021 from Khosla Ventures, LeapFrog Investments, Sistema Asia Fund and Chiratae Ventures. Entrackr reported the Series C valuation at $500–600 million and a $12 million employee stock-option buyback.
Strategic Objective
The documented objectives evolve across four stages.
2017: capacity and geography. The CEO said AI would let qualified nutritionists working from India serve customers beyond India. He also said the company aimed over the long run to use its knowledge graph to integrate with health, education and finance services.
2018: deeper AI. Management named photo-based food recognition and longer-horizon coaching as development targets.
2024: global expansion with profitability. The company said it would use new capital for global expansion, with a focus on the US, and for AI development. It also said it had reached operational profitability in India and expected to be EBITDA-positive by the end of FY25. The CEO’s stated mission was to put a high-acuity health coach in every person’s pocket.
2025–26: clinical and payer-linked care. The CEO told Reuters the vision was to become the largest global provider of patient support for GLP-1 drug makers across markets. In August 2026 the company merged with Berry Street to build an AI-powered, insurance-covered metabolic health platform in the US.
Analysis: The stated objective moves from reducing the cost of human coaching, to extending reach, to attaching the AI layer to payers and drug makers. The common thread is that AI is positioned as the scalable component and human expertise as the credibility and clinical component.
Campaign Architecture & Execution
The programme is best read as a stack of five components launched over nine years.
Jarvis (coach-facing AI). The Coach Co-Pilot, first launched in 2019, was described in December 2023 as equipping over 1,000 coaches with generative AI tools for diet and fitness plans, including call-to-note conversion and message drafting.
Ria (consumer-facing AI). Ria was unveiled at the company’s annual “Ignite” event in October 2017. A company executive said it would reach all users from January 2018. Access was initially limited to paying subscribers. Ria answers nutrition and fitness questions by audio and text. By February 2018 the company said Ria handled 77 percent of user questions, and that each of its 250 nutritionists and trainers could serve up to 250 clients, up from about 100 in 2016. These are company-reported figures, and no methodology was published.
Photo tracking and Ria 2.0. On 12 December 2023 the company adopted the “Healthify” name and announced Ria 2.0, a multimodal, multilingual conversational coach. Its Snap feature identifies foods from photos and calculates nutritional content. The new capabilities sat under a “Healthify Smart” programme.
Distribution partnerships. The same announcement included a Swiggy partnership letting users order meals aligned with Ria’s recommendations through the Healthify app. In December 2025 Novo Nordisk India and Healthify launched an AI-enabled patient support programme for people living with obesity. Analytics India Magazine described it as combining Ria with more than 500 dietitians and coaches.
Corporate structure. In 2026 Berry Street merged with Healthify, combining Ria with Berry Street’s network of more than 2,000 clinicians and its insurance-covered care.
Recognition and awareness activity is thinly documented. YourStory reported that OpenAI recognised Healthify at its DevDay event for multilingual and multimodal AI nutrition coaching. One report said HealthifyMe ran several nutrition-awareness campaigns in 2017.
Positioning & Consumer Insight
The positioning is consistent across eight years: AI paired with human expertise rather than AI alone. The December 2023 launch described AI coaching offered both directly and with human oversight. In 2024 the company claimed that its AI works alongside human coaches to achieve some of the highest outcome-to-cost ratios globally. That is a company claim, and no verified public information is available on the outcome data behind it.
Two commercial signals show how the company framed access and price. The 2019 split between a ₹299 AI-powered plan and plans costing up to ₹1,500 with human coaches created a clear price ladder. The CEO’s 2024 statement emphasised making healthy eating accessible regardless of ability to pay.
Localisation is the clearest documented insight. In October 2024 the company said it was expanding its AI to understand common food items, fitness habits and local dialects, so that guidance would be personalised and culturally relevant. It said the AI was being tailored to new markets such as the US, with features for local languages, food preferences and cultural habits. Food-and-language specificity is therefore the stated basis for both Indian differentiation and US entry.
One consumer-behaviour claim exists. In 2019 the CEO said Ria had become popular among more than 8 million users and that most people wanted to connect with her rather than with human trainers or nutritionists. It is a self-reported statement with no disclosed data.
Analysis: The documented record points to a “trust ladder.” Low-cost AI interaction comes first, human coaching is the paid upgrade, and clinical credibility, through drug-maker and clinician partnerships, comes later. The record does not show whether consumers actually experience the offer this way.
Media & Channel Strategy
The documented channels are mostly product-led and partnership-led. The first was an event-led launch, with Ria unveiled at Ignite in 2017. The second was a subscriber-first rollout, in which Ria was initially limited to paying subscribers. The third was commerce integration, through Swiggy. The fourth was B2B: the company runs a corporate-wellness vertical with partnerships in diagnostics, insurance and pharmaceuticals. The fifth was the pharma-led patient support route with Novo Nordisk India. The sixth is the US payer route. MobiHealthNews reported that Berry Street had joined Walmart’s Better Care Services platform and Amazon’s Health Benefits Connector in 2026. These are Berry Street’s channels, which Healthify’s AI now feeds into.
Analysis: The channel mix moves away from direct-to-consumer acquisition and toward channels where a third party (a food platform, an employer, a drug maker, an insurer) brings the user. The sources reviewed do not state the company’s reasons for this shift.
Business & Brand Outcomes
Scale claims. The CEO cited more than 8 million users across India, Southeast Asia and the Middle East in 2019. In October 2024 the company claimed over 40 million users across 300+ cities and more than 600 coaches. The definition of “user” is not disclosed. No verified public information is available on active users, paying subscribers or the share of interactions handled by Ria versus coaches today. The reported coach counts also differ across statements (1,000+ in December 2023, 600+ in October 2024, 500+ in December 2025), and no source reconciles them.
Financials. Figures come from different outlets and may not share one accounting basis.
FY21 to FY22: Entrackr reported revenue of ₹86.05 crore rising to ₹185.25 crore, with losses increasing from ₹19 crore to ₹157 crore. The FY22 figure included ₹72.1 crore of support services sold to the parent company.
FY23: Inc42 reported operating revenue of ₹228.76 crore, up 23.49 percent, and a net loss of ₹142 crore, down 10 percent.
FY25: Venture Intelligence reported about ₹178 crore in operating income and about ₹4.7 crore in net loss. I did not locate the underlying filing for this figure.
Profitability claims: in October 2024 the company stated it had reached operational profitability in India and was on track to be EBITDA-positive by the end of FY25. I found no independent verification of that status.
Funding and restructuring. The $45 million round closed in October 2024 brought total primary equity to approximately $125 million, according to the company. Inc42, citing sources, reported that about 150 employees (around 27 percent of the workforce) were laid off in a 2024 restructuring. That is a press report rather than a company confirmation.
Partnerships and corporate events. The Novo Nordisk India programme launched in December 2025. The 2026 Berry Street merger’s financial terms were not disclosed. Healthify’s investors remain invested in the combined company.
Strategic Implications
AI as a capacity multiplier on a human service. The documented path is a rise in clients per coach from 40 to 100 (2017) and to a claimed 250 (2018), alongside a lower-priced AI-only tier. This is a services-to-software transition, and the open question is whether margin gains accrue to the company or are competed away. The sources provide no verified unit-economics data.
A data asset that decays unless refreshed. The 2017 case rested on 150 million meals and 10 million coach messages from Indian users. The 2024 US plan states that food habits and dialects must be relearned for new markets. Proprietary data is a moat only inside the geography where it was collected.
Brand architecture as a strategic variable. In 2023 the company dropped “Me” to adopt a single global name. In 2026 its US operations were placed under the Berry Street brand, with Healthify retained in India and other markets. The documented sequence shows that the US route ran through an acquired clinical and insurance network, not through the Healthify consumer brand.
From consumer app to care infrastructure. The Novo Nordisk and Berry Street moves place Healthify’s AI inside pharma-funded and insurer-funded programmes. This potentially changes who the customer is, with payers and drug makers in place of individual subscribers.
Growth quality remains unresolved. The documented revenue record shows a pandemic-era jump, slower FY23 growth and a reported FY25 figure below FY23’s. Because the figures come from different outlets and bases, the trend cannot be stated with certainty. Management’s own 2024 statements put profitability ahead of growth.
Discussion Questions
Healthify positioned AI as both a cost-reduction tool and a user-facing product. What are the strategic risks of selling the same technology to the customer as “personal coach” and to the business as “labour substitute”?
A 2019 price ladder offered an AI-only plan far below human-coached plans. Evaluate the trade-offs between cannibalisation and funnel-building in this structure. What evidence would you need that the sources do not provide?
Healthify’s proprietary data was built on Indian food and language behaviour. How defensible is a localisation-based moat when entering a market such as the US, and what does the Berry Street merger imply about build, partner and acquire choices?
The company moved from a unified global name (2023) to a split brand architecture (2026). Assess the brand-equity implications for each market, using only the documented facts.
Revenue, user and coach figures in this case come from differing sources and bases. How should a strategist weigh company-claimed metrics against third-party-reported financials, and which disclosures would most change your assessment of the business?
Comments